Financial statements Acerbipharma
Balance sheet of Acerbipharma
Company age:
Age:
11 y. 2 m. 2 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of ACERBIPHARMA
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 281 238,64 | 637 297,11 | 687 868,56 | 526 176,30 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 281 238,64 | 637 297,11 | 687 868,56 | 526 176,30 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 281 238,64 | 637 297,11 | 687 868,56 | 526 176,30 |
| A. Equity | -271 826,40 | -183 739,96 | -562 963,28 | -791 276,24 |
| B. Liabilities and provisions for liabilities | 553 065,04 | 821 037,07 | 1 250 831,84 | 1 317 452,54 |
| I. Long-term liabilities | 518 119,06 | 777 411,65 | 1 143 162,07 | 1 249 362,07 |
| II. Short-term liabilities | 20 445,98 | 27 375,42 | 107 669,77 | 68 090,47 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.